{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:22:54Z","timestamp":1787847774426,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.4103\/sjg.sjg_183_25","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T06:00:09Z","timestamp":1753250409000},"page":"252-259","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Biologic therapy utilization trends in inflammatory bowel disease: A narrative review from Saudi Arabia"],"prefix":"10.4103","volume":"31","author":[{"given":"Syed A.","family":"Gardezi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Johns Hopkins HealthCare Aramco, Eastern Province, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turki","family":"AlAmeel","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Fahad Specialist Hospital, Dammam, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"AlSulais","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, King Fahad Specialist Hospital, Dammam, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"R1-20250929","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N Engl J Med"},{"key":"R2-20250929","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000518003","article-title":"Incidence, prevalence, and clinical epidemiology of inflammatory bowel disease in the Arab World: A systematic review and meta-analysis","volume":"6","author":"Mosli","year":"2021","journal-title":"Inflamm Intest Dis"},{"key":"R3-20250929","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3390\/diagnostics13132135","article-title":"A study of the epidemiology, clinical, and phenotypic characteristics of inflammatory bowel disease in the Northen-Central Region of Saudi Arabia","volume":"13","author":"Al-Fawzan","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R4-20250929","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.24911\/IJMDC.51-1689005973","article-title":"Inflammatory bowel disease in Saudi Arabia: A review article","volume":"7","author":"Almaghrabi","year":"2023","journal-title":"IJMDC"},{"key":"R5-20250929","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/sjg.sjg_277_22","article-title":"Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease","volume":"29","author":"Mosli","year":"2023","journal-title":"Saudi J Gastroenterol"},{"key":"R6-20250929","doi-asserted-by":"crossref","first-page":"685","DOI":"10.5009\/gnl19209","article-title":"Biologics for the management of inflammatory bowel disease: A review in tuberculosis-endemic countries","volume":"14","author":"Banerjee","year":"2020","journal-title":"Gut Liver"},{"key":"R7-20250929","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12962-019-0194-3","article-title":"Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia","volume":"17","author":"Alruthia","year":"2019","journal-title":"Cost Eff Resour Alloc"},{"key":"R8-20250929","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3748\/wjg.v23.i2.197","article-title":"Biosimilars in inflammatory bowel disease: A review of post-marketing experience","volume":"23","author":"Deiana","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R9-20250929","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1080\/13696998.2020.1791889","article-title":"The cost-effectiveness of biologic versus non-biologic treatments and the health-related quality of life among a sample of patients with inflammatory bowel disease in a tertiary care center in Saudi Arabia","volume":"23","author":"AlRuthia","year":"2020","journal-title":"J Med Econ"},{"key":"R10-20250929","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.3390\/jcm11144157","article-title":"Predictors of Anti-TNF therapy failure among inflammatory bowel disease (IBD) patients in Saudi Arabia:A single-center study","volume":"11","author":"Alharbi","year":"2022","journal-title":"J Clin Med"},{"key":"R11-20250929","doi-asserted-by":"crossref","first-page":"S620","DOI":"10.1016\/j.jval.2019.09.1146","article-title":"PGI23 cost of inflammatory bowel disease management in the Kingdom of Saudi Arabia","volume":"22","author":"Al Jedai","year":"2019","journal-title":"Value Health"},{"key":"R12-20250929","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4103\/sjg.sjg_101_24","article-title":"Short term effectiveness of ustekinumab versus vedolizumab in Crohn's disease after failure of anti-TNF agents:An observational comparative study design with a Bayesian analysis","volume":"30","author":"Alamer","year":"2024","journal-title":"Saudi J Gastroenterol"},{"key":"R13-20250929","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/sjg.sjg_7_24","article-title":"Clinical effectiveness and safety of ustekinumab in youth with refractory inflammatory bowel disease:A retrospective cohort study","volume":"31","author":"Alhadab","year":"2025","journal-title":"Saudi J Gastroenterol"},{"key":"R14-20250929","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/sjg.sjg_249_24","article-title":"The effectiveness of vedolizumab in advanced therapyexperienced ulcerative colitis patients: Real world data from the Inflammatory Bowel Disease of the Middle East (IBDME) Registry group","volume":"31","author":"Azzam","year":"2025","journal-title":"Saudi J Gastroenterol"},{"key":"R16-20250929","first-page":"04","article-title":"Combination of biologics and small molecules in inflammatory bowel disease: New trends in low doses","volume":"7","author":"El-Atrebi","year":"2024","journal-title":"Acta Sci Gastrointest Disord"},{"key":"R17-20250929","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2468-1253(22)00427-7","article-title":"Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA):A randomised, double-blind, controlled, phase 2, proof-of-concept trial","volume":"8","author":"Feagan","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R18-20250929","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S2468-1253(19)30414-5","article-title":"Small molecule oral targeted therapies in ulcerative colitis","volume":"5","author":"Shivaji","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R19-20250929","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MEG.0000000000001031","article-title":"Quality of life related to oral, subcutaneous, and intravenous biologic treatment of inflammatory bowel disease: A time trade-off study","volume":"30","author":"Holko","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R20-20250929","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(24)02151-2","article-title":"Driving down the cost of biologics:Lessons from a nationalised health-care system","volume":"404","author":"Russell","year":"2024","journal-title":"Lancet"},{"key":"R21-20250929","doi-asserted-by":"crossref","first-page":"145","DOI":"10.34172\/mejdd.2021.218","article-title":"Development of inflammatory bowel diseases registry software","volume":"13","author":"Keikavousi","year":"2021","journal-title":"Middle East J Dig Dis"}],"container-title":["Saudi Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_183_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:37:04Z","timestamp":1787845024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_183_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/sjg.sjg_183_25","relation":{},"ISSN":["1319-3767","1998-4049"],"issn-type":[{"value":"1319-3767","type":"print"},{"value":"1998-4049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"2025-05-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}